Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
The Journal of Biological Chemistry|December 19, 2018
Luminescence-activated nucleotide cyclase regulates spatial and temporal cAMP synthesisNyla Naim, Alex D White, Jeff M Reece, et al.Kidney International|September 25, 2008
Effects of the renal medullary pH and ionic environment on vasopressin binding and signalingElena A Zalyapin, Richard Bouley, Udo Hasler, et al.Endocrinology|November 26, 2020
Ligand-Dependent Effects of Methionine-8 Oxidation in Parathyroid Hormone Peptide AnaloguesEileen J Daley, Ashok Khatri, Thomas Dean, et al.Nature Communications|December 3, 2024
Fast-diffusing receptor collisions with slow-diffusing peptide ligand assemble the ternary parathyroid hormone-GPCR-arrestin complexJonathan Pacheco, Karina A Peña, Sofya Savransky, et al.Nature Chemical Biology|December 27, 2016
β2-adrenergic receptor control of endosomal PTH receptor signaling via GβγFrédéric G Jean-Alphonse, Vanessa L Wehbi, Jingming Chen, et al.The Journal of Biological Chemistry|November 8, 2013
Ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) and nuclear factor-κB (NF-κB): a feed-forward loop for systemic and vascular inflammationKristen L Leslie, Gyun Jee Song, Stacey Barrick, et al.Nature Chemical Biology|August 25, 2009
Sustained cyclic AMP production by parathyroid hormone receptor endocytosisSébastien Ferrandon, Timothy N Feinstein, Marian Castro, et al.Nature Chemical Biology|March 30, 2011
Retromer terminates the generation of cAMP by internalized PTH receptorsTimothy N Feinstein, Vanessa L Wehbi, Juan A Ardura, et al.Molecular Endocrinology (Baltimore, Md.)|February 7, 2009
GPCR and G proteins: drug efficacy and activation in live cellsJean-Pierre Vilardaga, Moritz Bünemann, Timothy N Feinstein, et al.Endocrinology|August 11, 2011
Visualizing microtubule-dependent vasopressin type 2 receptor trafficking using a new high-affinity fluorescent vasopressin ligandSylvia Chen, Matthew J Webber, Jean-Pierre Vilardaga, et al.Pageof 9